December 19, 2008 -- China Aoxing Pharmaceutical Company was given a production license by the SFDA for Ligustrazine Phosphate Injection to treat ischemic cerebrovascular disease or ischemic stroke. Ligustrazine is a TCM substance that promotes blood circulation by dilating blood vessels and slowing coagulation. More details...
Stock Symbol: (OTCBB: CAXG)
